Largest pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 52 pharmaceutical companies ranked by revenue, at HUF 31.64T, ahead of Eli Lilly (HUF 21.89T) and Merck & Co (HUF 21.84T). Figures as of 18 Nov 2026, 21:57 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- First
- Johnson & JohnsonHUF 31.64T
- Median
- HUF 1.08T
- Combined market value
- HUF 1699.17T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | HUF 31.64T | HUF 220.49T | HUF 91,591.75 | 2.15% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | HUF 21.89T | HUF 413.68T | HUF 464,424.24 | 2.32% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | HUF 21.84T | HUF 114.08T | HUF 46,276.17 | 3.90% down | 51% up | ||
| 4 | PfizerPFE · Health Care | HUF 21.02T | HUF 53.72T | HUF 9,424.51 | 1.44% down | 14% up | ||
| 5 | AbbVieABBV · Health Care | HUF 20.54T | HUF 169.8T | HUF 96,062.18 | 2.33% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | HUF 19.73T | HUF 93.12T | HUF 60,040.12 | 1.93% down | 2% up | ||
| 7 | NovartisNVS · Health Care | HUF 18.32T | HUF 98.45T | HUF 52,130.38 | 2.46% down | 25% up | ||
| 8 | SanofiSNY · Health Care | HUF 16.26T | HUF 38T | HUF 15,826.19 | 0.86% down | 4% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | HUF 16.19T | HUF 40.89T | HUF 20,004.42 | 2.92% down | 34% up | ||
| 10 | Novo NordiskNVO · Health Care | HUF 15.4T | HUF 58.37T | HUF 13,243.35 | 3.12% down | 17% down | ||
| 11 | Abbott LaboratoriesABT · Health Care | HUF 14.89T | HUF 60.78T | HUF 35,091.70 | 0.22% down | 17% down | ||
| 12 | GSKGSK · Health Care | HUF 14.56T | HUF 32.71T | HUF 16,316.56 | 1.34% down | 6% up | ||
| 13 | Takeda PharmaceuticalTAK · Health Care | HUF 9.48T | HUF 22.82T | HUF 7,143.95 | 1.71% down | 54% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | HUF 5.8T | HUF 16.55T | HUF 14,183.79 | 0.92% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | HUF 4.82T | HUF 32.85T | HUF 317,575.16 | 1.28% down | 36% up | ||
| 16 | ViatrisVTRS · Health Care | HUF 4.8T | HUF 7.81T | HUF 6,811.44 | 0.83% down | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | HUF 4.03T | HUF 45.68T | HUF 180,177.46 | 0.42% up | 27% up | ||
| 18 | ZoetisZTS · Health Care | HUF 3.18T | HUF 11.68T | HUF 28,740.40 | 2.50% up | 29% down | ||
| 19 | GrifolsGRFS · Health Care | HUF 2.8T | HUF 1.94T | HUF 2,844.82 | 1.85% down | 1% up | ||
| 20 | BeOne MedicinesONC · Health Care | HUF 1.79T | HUF 15.48T | HUF 135,557.13 | 2.34% down | 17% up | ||
| 21 | Elanco Animal HealthELAN · Health Care | HUF 1.58T | HUF 4.48T | HUF 8,967.73 | 3.29% up | 20% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | HUF 1.43T | HUF 5.34T | HUF 83,218.51 | 2.93% up | 37% up | ||
| 23 | GenmabGMAB · Health Care | HUF 1.25T | HUF 10.56T | HUF 17,119.29 | 1.91% down | 70% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | HUF 1.25T | HUF 6.72T | HUF 50,178.98 | 4.54% down | 66% down | ||
| 25 | Dr. Reddy's LaboratoriesRDY · Health Care | HUF 1.2T | HUF 4.19T | HUF 5,031.33 | 1.28% up | 5% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | HUF 1.08T | HUF 4T | HUF 20,632.49 | 4.99% up | 11% up | ||
| 27 | United TherapeuticsUTHR · Health Care | HUF 1.07T | HUF 8.26T | HUF 193,911.19 | 1.16% down | 23% up | ||
| 28 | Amneal PharmaceuticalsAMRX · Health Care | HUF 1.01T | HUF 2.56T | HUF 7,348.84 | 3.60% up | 83% up | ||
| 29 | Royalty PharmaRPRX · Health Care | HUF 798.8B | HUF 13.26T | HUF 23,064.19 | 0.01% down | 78% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | HUF 581.3B | HUF 1.69T | HUF 20,229.45 | 0.22% down | 20% down | ||
| 31 | AlkermesALKS · Health Care | HUF 495.7B | HUF 2.64T | HUF 15,735.51 | 3.08% up | 58% up | ||
| 32 | Legend BiotechLEGN · Health Care | HUF 345.6B | HUF 1.06T | HUF 5,457.89 | 0.87% up | 42% down | ||
| 33 | Madrigal PharmaceuticalsMDGL · Health Care | HUF 321.9B | HUF 3.11T | HUF 133,703.13 | 5.67% down | 24% down | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | HUF 317B | HUF 1.53T | HUF 9,199.48 | 1.59% up | 64% down | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | HUF 278.6B | HUF 2.05T | HUF 14,479.36 | 0.28% up | 10% up | ||
| 36 | Ascendis PharmaASND · Health Care | HUF 268.4B | HUF 5.96T | HUF 90,795.74 | 0.32% down | 28% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | HUF 255.7B | HUF 2.49T | HUF 22,768.63 | 3.25% down | 8% down | ||
| 38 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | HUF 227.6B | HUF 2.51T | HUF 31,924.44 | 0.06% down | 126% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | HUF 214.5B | HUF 2.37T | HUF 45,006.58 | 1.43% down | 7% down | ||
| 40 | TG TherapeuticsTGTX · Health Care | HUF 207B | HUF 3.36T | HUF 22,207.72 | 5.44% up | 107% up | ||
| 41 | InsmedINSM · Health Care | HUF 203.7B | HUF 8.83T | HUF 40,237.23 | 1.69% down | 40% down | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | HUF 175.1B | HUF 2.03T | HUF 31,064.62 | 0.59% up | 31% up | ||
| 43 | BridgeBio PharmaBBIO · Health Care | HUF 168.6B | HUF 5.1T | HUF 26,201.22 | 1.58% up | 17% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | HUF 164.8B | HUF 1.62T | HUF 16,874.11 | 1.68% down | 44% up | ||
| 45 | Ligand PharmaceuticalsLGND · Health Care | HUF 90B | HUF 2.01T | HUF 100,327.73 | 1.67% up | 43% up | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | HUF 63.7B | HUF 2.77T | HUF 39,981.96 | 2.08% up | 13% up | ||
| 47 | CytokineticsCYTK · Health Care | HUF 29.6B | HUF 2.4T | HUF 17,236.85 | 0.64% down | 20% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | HUF 15.5B | HUF 2.79T | HUF 42,709.23 | 2.00% up | 46% up | ||
| 49 | Roivant SciencesROIV · Health Care | HUF 2.8B | HUF 9.43T | HUF 13,008.25 | 0.05% up | 90% up | ||
| 50 | Dianthus TherapeuticsDNTH · Health Care | HUF 683.8M | HUF 1.59T | HUF 28,206.36 | 3.45% down | 113% up | ||
| 51 | Spyre TherapeuticsSYRE · Health Care | HUF 0 | HUF 3.24T | HUF 34,077.37 | 8.15% up | 286% up | ||
| 52 | Praxis Precision MedicinesPRAX · Health Care | HUF 0 | HUF 2.87T | HUF 102,504.17 | 0.04% up | 61% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 335.9 HUF). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies rank first by revenue?
Johnson & Johnson (HUF 31.64T), Eli Lilly (HUF 21.89T) and Merck & Co (HUF 21.84T) are the top three of the 52 pharmaceutical companies ranked by revenue as of 18 Nov 2026, 21:57 UTC.
How many pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies worth together?
The 52 pharmaceutical companies ranked by revenue have a combined market value of HUF 1699.17T as of 18 Nov 2026, 21:57 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by revenue”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.